Dr. Ge Li serves as Chairman and CEO of WuXi AppTec, a pivotal investor in Schrödinger, a company focused on molecular design software for pharmaceutical, biotech, and materials research, along with progressing a drug discovery pipeline. Since its inception in 2000, Dr. Li has led WuXi AppTec as a scientist and entrepreneur, pioneering an integrated, open-access R&D platform to support global innovators in medicine and healthcare product development. This approach has propelled WuXi AppTec into a prominent global entity, offering diverse services spanning small molecule drugs, cell and gene therapies, and emerging modalities. Notably, the company's unique CRDMO and CTDMO models contribute to its role as an enabler for innovative partners worldwide.